Common Stock |
3 Months Ended | |||
|---|---|---|---|---|
May 31, 2025 | ||||
| Equity [Abstract] | ||||
| Common Stock |
Share transactions for the three months ended May 31, 2025: The company accrued 50,000 shares of common stock issuable with a fair value of $34,250 pursuant to Director Agreements (Note 10(a) and Note 10(b)). Share transactions for the three months ended May 31, 2024: The Company accrued 83,332 shares of common stock issuable with a fair value of $83,332 pursuant to a Director Agreement (Note 10(a)) and a Director and Officer Agreement (Note 10(b)). |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|